Effect of SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists on diabetic foot-related extremity amputation in patients with T2DM: A meta-analysis

Yaping Du(Fourth Hospital of Hebei Medical University), Lei Bai(Fourth Hospital of Hebei Medical University), Bingge Fan(Fourth Hospital of Hebei Medical University), Haixia Ding(Fourth Hospital of Hebei Medical University), Haiyan Ding(Fourth Hospital of Hebei Medical University), Lin Hou(Hebei Medical University), Hongfang Ma(Fourth Hospital of Hebei Medical University), Na Xing(Fourth Hospital of Hebei Medical University), Fujun Wang
Primary care diabetes
December 17, 2021
10.1016/j.pcd.2021.12.007
Cited by 24

Abstract

Related Papers

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al.|New England Journal of Medicine|2017|7.7k
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Hiddo J.L. Heerspink, Bruce A. Perkins, David Fitchett et al.|Circulation|2016|1.3k
Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
Despoina Vasilakou, Thomas Karagiannis, Eleni Athanasiadou et al.|Annals of Internal Medicine|2013|899
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
Jason Wu, Celine Foote, Juuso Blomster et al.|The Lancet Diabetes & Endocrinology|2016|466
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
Yuliya Lytvyn, Petter Bjornstad, Jacob A. Udell et al.|Circulation|2017|460